Scott Jeffers
Technik-/Wissenschafts-/F&E-Leiter bei GENSIGHT BIOLOGICS S.A.
Aktive Positionen von Scott Jeffers
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 | - |
Karriereverlauf von Scott Jeffers
Ehemalige bekannte Positionen von Scott Jeffers
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Ausbildung von Scott Jeffers
| Purdue University | Doctorate Degree |
| Colorado State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Frankreich | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Commercial Services |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Börse
- Insiders
- Scott Jeffers
- Erfahrung
